Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
boston blog main
biotech
clinical trials
san francisco blog main
san francisco top stories
cancer
national
national top stories
new york blog main
new york top stories
sanofi
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
andrew berens
anirvan ghosh
artificial intelligence
astrazeneca
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cerovene
cholesterol
covid-19
crispr
data
deals
What
announced
5
×
medicine
ceo
drug
plans
cancer
medicines
week
aces
acquisitions
alex
approval
area
based
bay
big
bio
biopsy
blood
blueprint
buildout
chasing
cholesterol
close
collaboration
collabs
company
covid
daniel
deadly
deal
deciphera
developing
discovery
entered
fda
filing
firm
flexible
forms
Language
unset
5
×
Current search:
unset
×
announced
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
